• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Finance

Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

November 2, 2019 Microbiome Times

Chardan Healthcare Acquisition Corp. (NYSE: CHAC), a special purpose acquisition company sponsored by affiliates of Chardan Capital Markets LLC (“Chardan”), announced today the closing of its merger with BiomX Ltd. (“BiomX”) a microbiome company developing […]

Finance

Arranta Bio announces $82M in new funding, and a strategic partnership with Thermo Fisher Scientific

November 2, 2019 Microbiome Times

Arranta Bio (“Arranta”) announced the completion of an $82 million funding round and a strategic partnership with Thermo Fisher Scientific. Formed in May 2019, Arranta’s goal is to be the best-in-class microbiome contract development and […]

Editor's Choice

Group examines the unique challenges of clinical trials for development of microbiotic medicinal products, including live biotherapeutic products

October 29, 2019 Kristina Campbell

Many individuals living with chronic disease—whether it’s asthma, allergies, atopic dermatitis, type 2 diabetes, or another condition—readily confirm their therapeutic options leave a lot to be desired. Even if an existing drug product deals adequately […]

Pharma & Human Health

Half of all commonly used drugs profoundly affecting the gut microbiome, warn experts

October 26, 2019 Microbiome Times

A new study presented at UEG Week 2019 has found that 18 commonly used drug categories extensively affect the taxonomic structure and metabolic potential of the gut microbiome. Eight different categories of drugs were also […]

Editor's Choice

Standardization in microbiome measurements Considerations from sampling to analysis

October 25, 2019 Microbiome Times
Pharma & Human Health

Phage lysin stabilizes vaginal microbiome: Phagomed accelerates R&D program against bacterial vaginosis.

October 23, 2019 Microbiome Times

Vienna-based biotech company PhagoMed Biopharma GmbH has discovered a novel drug candidate for the treatment of Bacterial Vaginosis and the re-stabilization of the vaginal microbiome. A dedicated R&D team has been established to develop this […]

Editor's Choice

The Lactobacillus Taxonomy change is coming: why, and how to make the most of it?

October 17, 2019 Marco Pane and Nina Vinot

1. What is taxonomy, what’s the reality behind it – and why do we need it anyway? Taxonomy is the branch of science concerned with the classification of organisms. Since Darwin, it has allowed to […]

Editor's Choice

Toward Clinical Utility of Metagenomic Data: Interview with Dr Joël Doré

October 17, 2019 Microbiome Times
Finance

Azitra Completes $14 Million Series A Financing

October 16, 2019 Microbiome Times

Azitra Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that it has closed a $14 million Series A financing. The financing was led by KdT Ventures in […]

Editor's Choice

5-minute Microbiome Science Roundup: September 2019

October 16, 2019 Kristina Campbell

Through the month of September, the microbiome scientific literature had some particularly interesting contributions related to human health. First up is a pair of papers on the significance of serotonin that’s made in the gut, […]

Finance

BiomeSense Raises $2 Million in Seed Round Funding

October 11, 2019 Microbiome Times

BiomeSense, a microbiome startup developing a novel biosensor and analytics platform for daily gut microbiome tracking, announced today that it has closed its $2 million seed funding round. The lead investor was BioX Clan, which […]

Posts navigation

« 1 … 55 56 57 … 86 »

QIAGEN’S NEW HIGH-THROUGHPUT BENCHTOP AUTOMATION SYSTEM

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
    April 8, 2026
  • Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
    March 24, 2026
  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
sign up

Sign up to the Microbiome Times newsletter